The Unilever Foods McCormick deal sent shares in ULVR down 5% on announcement, but for income investors the sell-off may be worth a closer look. Mechanically, 3,566 shares currently generate £1,443 in annual dividends, a level that matches what the National Living Wage Foundation says workers need as a second income to maintain a decent standard of living.
What the Unilever Foods McCormick deal actually delivers
The transaction is structured as a Reverse Morris Trust. Unilever retains a 9.9% stake in the combined business, intending to sell that down gradually, while its existing shareholders will own 55.1% of the combined entity.
That is not a clean exit. Residual exposure to GLP-1 headwinds and consumer trade-down risk remains.
The headline deal value is $44.8bn. According to Unilever’s Form 425 investor presentation, Unilever receives $15.7bn in cash consideration. The filing also sets out targeted annual run-rate cost synergies of $600m net of reinvestment, with $100m earmarked for reinvestment, and projects a close in mid-2027, subject to shareholder and regulatory approvals.
Unilever Foods contributed €10.7bn in sales within the transaction perimeter, with the pro forma combined group carrying roughly €39bn in FY2025 turnover, per the same Form 425 filing.
Two criticisms have dominated the reaction. First, critics argue that Fernando Fernandes was appointed chief executive to reinvigorate the food division, not to sell it. Second, shareholders who wanted a clean break from foods still own the bulk of the division through their 55.1% stake in the combined entity.
On the first point, the competitive context matters. Kraft Heinz’s Q4 2025 earnings call showed organic net sales fell 4.2% in the quarter, with volume and mix down 4.7 percentage points. Food Business News reports the new Kraft Heinz chief executive cited early signs of a turnaround in Q1 2026, but the broader packaged food sector has been under sustained pressure. Campbell’s, separately, ruled out 2026 sales growth entirely. The market for packaged food assets is not thriving, which limits the alternatives available to any seller.
What remains after the Unilever Foods McCormick transaction
Unilever’s 2025 full-year results (on a continuing basis, excluding Ice Cream) showed total turnover of €50.5bn, down 3.8%, with underlying operating profit of €10.1bn and an underlying operating margin of 20.0%. The rump Unilever, once the foods business transfers, is tilted towards higher-growth categories.
Beauty and Wellbeing delivered underlying sales growth of 4.3% in full-year 2025. Personal Care grew 4.7%. Free cash flow came in at €5.9bn at 100% conversion, comfortably covering €4.3bn in dividends.
The $15.7bn cash proceeds from the deal will part-fund €6bn in share buybacks running through to 2029.
Unilever completed the demerger of its Ice Cream business into The Magnum Ice Cream Company in 2025, retaining a 19.85% stake. Its 2025 Form 20-F targets underlying sales growth of 4–6% for full-year 2026, with at least 2% underlying volume growth and modest margin improvement.
The dividend yield is close to a 10-year high. Free cash flow in 2025 covered the dividend comfortably, which argues against the case that this is a deteriorating-business yield trap.
For income investors, the arithmetic is straightforward: 3,566 ULVR shares produce £1,443 a year in dividends at the current payout. The business funding those dividends is becoming leaner, with the drag from a structurally challenged food division in the process of being removed.
The 2026 sales growth target of 4–6% represents the clearest near-term test of whether management’s optimism about the stripped-down portfolio is justified.
